Editorial: ways to reduce emergency department utilisation among IBD patients (English)
- New search for: Mak, W. Y.
- New search for: Ng, S. C.
- New search for: Mak, W. Y.
- New search for: Ng, S. C.
In:
Alimentary Pharmacology & Therapeutics
;
47
, 9
;
1325-1326
;
2018
- Article (Journal) / Electronic Resource
-
Title:Editorial: ways to reduce emergency department utilisation among IBD patients
-
Contributors:Mak, W. Y. ( author ) / Ng, S. C. ( author )
-
Published in:Alimentary Pharmacology & Therapeutics ; 47, 9 ; 1325-1326
-
Publisher:
-
Publication date:2018-05-01
-
Size:2 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents – Volume 47, Issue 9
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1235
-
Issue Information| 2018
- 1238
-
Systematic review with meta‐analysis: neuroimaging in hepatitis C chronic infectionOriolo, G. / Egmond, E. / Mariño, Z. / Cavero, M. / Navines, R. / Zamarrenho, L. / Solà, R. / Pujol, J. / Bargallo, N. / Forns, X. et al. | 2018
- 1253
-
Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel diseaseVollebregt, P. F. / van Bodegraven, A. A. / Markus‐de Kwaadsteniet, T. M. L. / van der Horst, D. / Felt‐Bersma, R. J. F. et al. | 2018
- 1261
-
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5‐year study on a large number of strainsGatta, L. / Scarpignato, C. / Fiorini, G. / Belsey, J. / Saracino, I. M. / Ricci, C. / Vaira, D. et al. | 2018
- 1270
-
Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal diseaseTaft, T. H. / Triggs, J. R. / Carlson, D. A. / Guadagnoli, L. / Tomasino, K. N. / Keefer, L. / Pandolfino, J. E. et al. | 2018
- 1278
-
Direct‐acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort studySinger, A. W. / Reddy, K. R. / Telep, L. E. / Osinusi, A. O. / Brainard, D. M. / Buti, M. / Chokkalingam, A. P. et al. | 2018
- 1288
-
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infectionvon Felden, J. / Vermehren, J. / Ingiliz, P. / Mauss, S. / Lutz, T. / Simon, K. G. / Busch, H. W. / Baumgarten, A. / Schewe, K. / Hueppe, D. et al. | 2018
- 1296
-
The adverse effects of interferon‐free regimens in 149 816 chronic hepatitis C treated Egyptian patientsAttia, D. / El Saeed, K. / Elakel, W. / El Baz, T. / Omar, A. / Yosry, A. / Elsayed, M. H. / Said, M. / El Raziky, M. / Anees, M. et al. | 2018
- 1306
-
Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patientsChuang, W.‐L. / Jia, J. / Chan, H. L. Y. / Han, K.‐H. / Tanwandee, T. / Tan, D. / Chen, X. / Gane, E. / Piratvisuth, T. / Chen, L. et al. | 2018
- 1317
-
Editorial: symptom association probability during reflux testing—what is the gain?Triggs, J. R. / Kahrilas, P. J. et al. | 2018
- 1318
-
Editorial: are the “miraculous” direct‐acting antiviral (DAA) regimens really safe?Papanikolaou, I. S. / Papadimitropoulos, V. et al. | 2018
- 1319
-
Editorial: patient‐reported outcomes in chronic HCV—a PROMISing approach to an ongoing problemAcharya, C. / Bajaj, J. S. et al. | 2018
- 1320
-
Editorial: patient‐reported outcomes in chronic HCV—a PROMISing approach to an ongoing problem. Authors' replyEvon, D. M. et al. | 2018
- 1321
-
Editorial: vancomycin – a promising option for the treatment of primary sclerosing cholangitis?Chapman, R. W. et al. | 2018
- 1323
-
Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease—following the fate of anti‐TNF‐alpha agents?Fragaki, M. / Karmiris, K. et al. | 2018
- 1324
-
Editorial: the sphincter of Oddi strikes again—eluxadoline illuminates a controversial mechanism for the pathogenesis of acute pancreatitisCoté, G. A. et al. | 2018
- 1325
-
Editorial: ways to reduce emergency department utilisation among IBD patientsMak, W. Y. / Ng, S. C. et al. | 2018
- 1327
-
Editorial: isolated duodenal eosinophilia—clinical condition or just seeing spots?Singh, P. / Leffler, D. A. et al. | 2018
- 1328
-
Editorial: optimal dose of carvedilol in portal hypertension…nearly thereTripathi, D. / Stanley, A. J. et al. | 2018
- 1329
-
Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' replyReiberger, T. / Ferlitsch, A. et al. | 2018
- 1330
-
Editorial: the prevalence of Helicobacter pylori infection worldwide—knowns and unknownsTsipotis, E. / Leontiadis, G. I. et al. | 2018
- 1331
-
Editorial: the prevalence of Helicobacter pylori infection worldwide—knowns and unknowns. Authors' replyZamani, M. / Derakhshan, M. H. / Zamani, V. / Shokri‐Shirvani, J. et al. | 2018
- 1332
-
Editorial: alleviating the itch—the safety of rifampicin in the real worldGordon‐Walker, T. T. et al. | 2018
- 1334
-
Letter: infliximab concentrations during induction therapy—one size does not fit allPapamichael, K. / Cheifetz, A. S. et al. | 2018